{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013433","form_type":"8-K","ticker":"NSPR","cik":"0001433607","company_name":"InspireMD, Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.280993+00:00","generated_at":"2026-05-20T01:18:36.739894+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"InspireMD appoints Michael Lawless as CFO, succeeding Craig Shore","bullets":["Michael Lawless appointed CFO effective on/before June 30, 2025; succeeds Craig Shore who served ~15 years.","Base salary of $375,000 annually, plus performance bonus up to 50% of base salary.","Inducement grant: 212,000 stock options and 465,000 restricted shares, vesting over 3 years under NASDAQ Rule 5635(c)(4).","Employment agreement has 3-year initial term with automatic renewal; severance includes 6 months base salary (non-CIC) or 12 months (CIC).","Lawless previously CFO of Lifeward (LFWD) and held senior finance roles at Azenta, PerkinElmer, and Momenta Pharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013433","json":"https://secwatch.observer/filing/0001641172-25-013433.json","markdown":"https://secwatch.observer/filing/0001641172-25-013433.md","text":"https://secwatch.observer/filing/0001641172-25-013433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1433607/000164117225013433/0001641172-25-013433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1433607/000164117225013433/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:18:36.739894+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8068129873","claim":"Michael Lawless was appointed as Chief Financial Officer at InspireMD, Inc..","evidence_excerpt":"On June 2, 2025, InspireMD, Inc. (the “ Company ”) appointed Michael Lawless as Chief Financial Officer of the Company, effective on or before June 30, 2025 (the “ Effective Date ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1433607/000164117225013433/0001641172-25-013433-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"afa395492e","claim":"Craig Shore was terminated as Chief Financial Officer at InspireMD, Inc..","evidence_excerpt":"On the Effective Date, Mr. Lawless will succeed Craig Shore, whose employment as the Company’s Chief Financial Officer will be terminated simultaneous with Mr. Lawless’s appointment.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1433607/000164117225013433/0001641172-25-013433-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}